WHO, WIPO, WTO Trilateral Cooperation on Public Health, IP and Trade

1 - 9 / 9 items

WIPO, WHO, WTO Joint Technical Symposium on Antimicrobial Resistance: How to Foster Innovation, Access and Appropriate Use of Antibiotics?

WIPO-WHO-WTO/IP/GE/16
October 25, 2016 (Geneva, Switzerland)
WIPO New Conference Hall (start time 9.30 a.m.)
Antimicrobial resistance is one of the most pressing challenges for humanity. It affects all areas of health, involves many sectors and has an impact on the whole of society. Increasing resistance threatens to roll back the achievements of modern medicine as many medicinal procedures rely on effective antibiotics. Antibiotics, more than other medicines, can be considered a public good for which society has a collective responsibility. The Symposium will offer a forum to exchange views and experiences, to achieve a better understanding of the global challenge of antimicrobial resistance and to envisage possible ways forward.

Access to Medicines: Pricing and Procurement Practices

WIPO-WTO/WHO/GE/10
July 16, 2010 (Geneva, Switzerland)
The World Health Organization (WHO), WIPO and the World Trade Organization (WTO) jointly organized this technical symposium at the Centre William Rappard in the WTO in Geneva